Circle Pharma

David Earp, president and CEO
David Earp, president and CEO
Country: USA | Funding: $207.5M (+)

Website: https://circlepharma.com

Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides with applications in Rb-dysregulated cancers and cyclin-E-dependent malignancies

Competitors